References
- Poulin Y. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept. J Cutan Med Surg. 2009;13(4):221–225.
- Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: First 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9(1):1–14.
- Manni E, Barachini P. Psoriasis induced by infliximab in a patient suffering from Crohns disease. Int J Immunopathol Pharmacol. 2009;22(3):841–844.
- Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: A case series. J Rheumatol. 2007;34(2):380–385.
- Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology. 2005;129(3):827–836.
- Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn’s disease. J Am Acad Dermatol. 2003;48(6):805–821.
- Piruzian ES, Ishkin AA, Nikol’skaia TA, Abdeev RM, Bruskin SA. [The comparative analysis of psoriasis and Crohn disease molecular-genetical processes under pathological conditions.] Mol Biol (Mosk). 2009;43(1):175–179.